LabCompass

Zhe Li

Medicine · Purdue University West Lafayette

Established · publishing since 2000Rising activity

Publications

89

Citations

1,780

Est. group size

Recurring co-author estimate

Active years

27

Publishing since 2000

Research summary
AI-generated

This researcher's core work focuses on how hormones like estrogen and genetic factors influence the origins of cancers in reproductive tissues, particularly breast, ovarian, and fallopian tube cancer, including how immune system pathways contribute to tumor formation and treatment response. The publication record also includes a broad mix of other topics such as gastric cancer, kidney disease, and dietary supplements, suggesting either collaborative work across many labs or a shared name across multiple contributing researchers.

Cancer initiation and origin (breast, ovarian, fallopian tube)Hormone (estrogen) signaling in cancerTumor immunology and immune-based cancer therapyCancer genetics and epigenetics (e.g., RUNX1, 53BP1, EZH2)Stem/progenitor cell biology in cancer-prone tissues

Publication output has fluctuated over the last decade, dipping around 2020-2021 and then gradually increasing again from 2022 through 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 4.6/year recently
2017: 9 publications9172018: 3 publications182019: 9 publications9192020: 5 publications202021: 1 publication212022: 3 publications222023: 5 publications232024: 7 publications242025: 6 publications252026: 2 publications26
Recent publications
Publishes in
  • bioRxiv (Cold Spring Harbor Laboratory)×4
  • Nature Communications×3
  • Cancers×3
  • Chin J Reprod Contracep×3
  • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease×2
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 20, 2026.

Claim or correct this profile